natgillin/translations-raw huggingface dataset:
These enzymes can be found in some receptors at the surface of cancer cells, where they are involved in the growth and spread of cancer cells and in the blood vessels that supply the tumours, where they are involved in the development of new blood vessels.
Neid leidub teatud retseptorites vähirakkude pinnal, kus osalevad vähirakkude kasvus ja levikus, ning kasvajaid varustavates veresoontes, kus osalevad uute veresoonte tekkes.
Treatment with Sutent should be started by doctors who have experience in administering cancer medicines.
Ravi Sutentiga peab alustama vähiravimite manustamises kogenud arst.
It is used after treatment with imatinib (another cancer medicine) has failed;
Ravimit kasutatakse pärast seda, kui ravi vähiravimi imatiniibiga on ebaõnnestunud;
• metastatic renal cell carcinoma, a type of kidney cancer, that has spread to other parts of the body;
• metastaatiline neerurakk-kartsinoom - teatud liiki neeruvähk, mis on levinud organismis ka mujale;
• gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel where there is uncontrolled growth of cells in the supporting tissues of these organs.
• gastrointestinaalne stromaaltuumor (GIST) - teatud liiki mao- ja soolevähk, mille korral nende elundite tugikudede rakud hakkavad takistamatult vohama.
The active substance in Sutent, sunitinib, is a protein kinase inhibitor.
Sutenti toimeaine sunitiniib on proteiinkinaasiinhibiitor ehk aine, mis blokeerib teatud ensüüme proteiinkinaase.
Sutent is used in patients with GISTs that cannot be removed with surgery or have spread to other parts of the body.
Sutenti kasutatakse gastrointestinaalsete stromaaltuumoritega täiskasvanute raviks, kui neid tuumoreid ei saa kirurgiliselt eemaldada või kui vähk on levinud organismis ka mujale.
What is Sutent used for?
Milleks Sutenti kasutatakse?
In metastatic renal cell carcinoma, patients taking Sutent lived for an average of 47.3 weeks without their disease worsening, compared with 22.0 weeks in the patients receiving interferon alfa.
Metastaatilise neerurakk-kartsinoomi korral oli aeg haiguse süvenemiseni Sutenti saanute rühmas keskmiselt 47,3 nädalat ja alfainterferooni rühmas 22,0 nädalat.
Sutent was more effective than placebo in treating GIST and pancreatic neuroendocrine tumours.
Sutent oli gastrointestinaalse stromaaltuumori ja pankrease neuroendokriintuumorite ravis platseebost efektiivsem.
How is Sutent used?
Kuidas Sutenti kasutatakse?
Patients with GIST taking Sutent lived for an average of 26.6 weeks without the disease getting worse, compared with 6.4 weeks in the patients taking placebo.
Gastrointestinaalse stromaaltuumori korral oli progresseerumiseta elulemus Sutenti saanud patsientidel keskmiselt 26,6 nädalat ja platseebot saanutel 6,4 nädalat.
For pancreatic neuroendocrine tumours the figures were 11.4 months in the Sutent group and 5.5 months in the placebo group.
Pankrease neuroendokriintuumorite korral oli haiguse süvenemiseni kulunud aeg Sutenti saanud patsientidel keskmiselt 11,4 kuud ja platseebot saanud patsientidel 5,5 kuud.
How has Sutent been studied?
Kuidas Sutenti uuriti?
The medicine can only be obtained with a prescription.
Sutent on retseptiravim.
EU number
Müügilo nr Euroopa Liidus
83607 Holzkirchen Germany
25, 83607 Holzkirchen Saksamaa
OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF SANOHEX AND ASSOCIATED NAMES (SEE ANNEX I)
SANOHEXI JA SELLEGA SEOTUD NIMETUSTE (VT I LISA) TEADUSLIKU HINDAMISE ÜLDKOKKUVÕTE
The Applicant also decided to generate additional spacer data in order to obtain more reliable information on the particle size distribution when the compared inhalers are fitted with their respective spacer devices.
Taotleja otsustas esitada ka täiendavad vahemahutiga saadud andmed, et saada usaldusväärsemat teavet osakeste suurusjaotuse kohta, kui võrreldavate inhalaatorite külge on kinnitatud neile sobiv vahemahuti.
the CHMP has recommended the granting of the Marketing Authorisations for which the valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure are set out in Annex III for Sanohex and associated names (see Annex I).
on komitee soovitanud müügilubade andmist, milles kehtiv ravimi omaduste kokkuvõte, märgistus ja pakendi infoleht on lõplikud versioonid, mis saavutati koordineerimisrühma menetlusega ning mis on esitatud Sanohexi ja sarnaste nimetuste puhul III lisas (vt I lisa).
Sanohex is a metered dose aerosol inhaler containing a suspension formulation of salbutamol sulphate 100 µg/spray, with HFA 134a as propellant.
Selles on suspensioon, mis sisaldab salbutamoolsulfaati annuses 100 µg pihustuse kohta ja propellendiks on HFA 134a.
- the CHMP considered that Sanohex and the reference product possess the same systemic safety profile, as demonstrated by the bioequivalence in systemic levels (AUC and Cmax),
- komitee leidis, et Sanohexil ja võrdlusravimil on samasugune süsteemne ohutusprofiil, mida näidati bioekvivalentsuse alusel süsteemsetel tasemetel (AUC ja Cmax),
The marketing applications were submitted as hybrid applications under Article 10(3) of Directive 2001/83/EC and the EU reference product is Sultanol Dosier-Aerosol 100 μg/dose, Druckgasinhalation, suspension, (GlaxoSmithKline).
Euroopa Liidus on võrdlusravimiks Sultanol Dosier-Aerosol 100 μg annuses, Druckgasinhalation, suspensioon (GlaxoSmithKline).
The pharmacokinetic bioequivalence data also confirmed that Sanohex and the reference product possess the same systemic safety profile since bioequivalence in systemic levels (AUC and Cmax) have been shown, when used with or without a spacer.
Farmakokineetilise bioekvivalentsuse andmed kinnitasid samuti, et Sanohexil ja võrdlusravimil on samasugune süsteemne ohutusprofiil, sest bioekvivalentsust näidati süsteemsetel tasemetel (AUC ja Cmax) nii vahemahutiga kui ka ilma.
List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Ravimi nimetuste nimekiri, ravimvorm, ravimpreparaadi tugevus, manustamisviis, müügiloa hoidjad liikmesriikides liikmesriik Müügiloa hoidja
164 94 Kista
164 94 Kista Sweden
Hungary Baxter Hungary Kft. Népfürdő u. 22.
Baxter Hungary Kft. Népfürdö u. 22.
Sweden Baxter Medical AB Box 63
Baxter Medical AB Box 63
Germany Baxter Deutschland GmbH Edisonstr.
Saksamaa Baxter Deutschland GmbH Edisonstr.
Kifissias Avenue 368, Halandri, 152 33 Greece
Diophar SA Kifissias 368 Halandri 15233 Greece
Baxter MédicoFarmacêutica, Lda.
Baxter Médico Farmacêutica Lda
Baxter SPA piazzale dell' industria 20 - 00144 Roma, Italy
Piazzale dell'Industria 20 00144 Roma Italy
11 g/l amino acids and 1,25 mmol/l Ca.
11 g/l Aminohapped ja 1,25 mmol/l Ca.
Romania BAXTER d.o.o.
Rumeenia BAXTER d.o.o.
Slovak Republic
Slovaki Vabariigi
Belgium Baxter SA Boulevard R. Branquart 80 7680 Lessines Belgium
Boulevard R. Branquart 80 7680 Lessines Belgium
Denmark Baxter A/S, Gydevang 43, DK-3450 Allerød
Baxter A/S Gydevang 43 3450 Allerød Denmark
Luxembourg Baxter SA, Bd René Branquart 80, B-7860 Lessines Belgium
Luksemburg Baxter S.A. Bd René Branquart 80 B-7860 Lessines Belgium
Norfolk IP24 3SE United Kingdom
Thetford IP24 3SE United Kingdom
Box 270 Valimotie 15A 00381
Box 270 Valimotie 15A 00381 Helsinki Finland
Avenue louis Pasteur ZA de Coignières Maurepas 78310 Maurepas France
Prantsusmaa Baxter S.A.S Avenue louis Pasteur 78310 ZA de Coigneres 78310 Maurepas France
Zelezna cesta 14, SI-1000 Ljubljana
Zelezna cesta 14, SI-1000 Ljubljana, Slovenia
Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeistof
Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeis t of
7,5% (icodextrin)
7,5% (Ikodekstriin)
4.480 g, Sodium chloride Ph. Eur.
4.480 g, Naatriumkloriid Ph. Eur.
0.152, Sodium Lactate Ph. Eur.
0.152, Naatriumlaktaat Ph. Eur.
0.0257 % w/v, Magnesium Chloride Ph. Eur.
0.0257 % w/v, magneesiumkloriid Ph. Eur.
Glucose Monohydrate Ph. Eur.1.1, Sodium Chloride Ph. Eur.
Glükoosmonohüdraat Ph. Eur.1.1, Naatriumkloriid Ph. Eur.
Natriumklorid Baxter 9 mg/ml solution for infusion intravenous use
Natriumklorid Baxter 9 mg/ml
L-Tyrosine Ph.Eur.
L-Türosiin Ph.Eur.
Netherlands Baxter B.V., Kobaltweg 49, 3542 CE Utrecht
Holland Baxter B.V Kobaltweg 49
BAXTER S.L.
Baxter S.A.
Zona Industrial da Abrunheira - Edifício 10Sintra Business Park, 2710-089 Sintra Portugal
Edificio 10 Sintra Business Park,
1.071 g, Calcium chloride dihydrate Ph.Eur.
1.071 g, kaltsiumkloriid dihüdraat Ph.Eur.
75.00 g/l Icodextrine
75.00 g/l Ikodekstriin
1.1, Sodium Chloride Ph. Eur.
1.1, Naatriumkloriid Ph. Eur.
0.54 % w/v, Sodium (S)-lactate 0.45 % w/v, Calcium Chloride Ph. Eur.
0.54 % w/v, naatrium (S)-laktaat 0.45 % w/v, kaltsiumkloriid Ph. Eur.
0.184 g, Magnesium chloride hexahydrate Ph.Eur.
0.184 g, Magneesiumkloriidheksahüdraat Ph.Eur.
Extraneal (Icodextrin 7.5%) Solution for peritoneal dialysis icodextrin 75g/l; sodium chloride 5.4g/l; calcium chloride 0,257g/l; magnesium chloride 0.051g/l; sodium s-lactate 4.5g/l
Extraneal (lcodextrin 7.5%) Solution for peritoneal dialysis ikodekstriin 75g/l; naatriumkloriid 5.4g/l; kaltsiumkloriid 0,257g/l; magneesiumkloriid 0.051g/l; naatrium s-laktaat 4.5g/l
7,5 % 75 g / 1000 ml peritoneal use
7,5 % 75g/1000 ml
Sodium Hydroxide 52.25 g Water for Injections to 100 ml
Piimhape 139 g Naatriumhüdroksiid 52.25 g Süstevesi kuni 100 ml
75 g/l icodextrine
75 g/l Ikodekstriin
Lithuania Baxter Oy, P.O.
Baxter Oy P.O.
6.43, Calcium Chloride Dihydrate Ph.
6.43, Kaltsiumkloriiddihüdraat Ph.
Baxter Healthcare S.A. Moneen Road Castlebar
Baxter Healthcare SA Moneen Road Castlebar
Slovenia Baxter d.o.o., Zelezna cesta 18 , Ljubljana, SI-1000, Slovenia
Sloveenia Baxter d.o.o., Zelezna cesta 18 ,Ljubljana, SI-1000, Slovenia
Icodextrin 7.5 % w/v, Sodium Chloride Ph.
Ikodekstriin 7.5 % w/v, naatriumkloriid Ph. Eur.
0.951 g, L-Valine Ph.Eur.
0.951 g, L-Valiin Ph.Eur.
0.646 g, L-Serine Ph.Eur.
0.646 g, L-Seriin Ph.Eur.
3.36, Potassium Chloride Ph. Eur.
3.36, Kaaliumkloriid Ph. Eur.
Nutrineal PD4 with 1.1% Amino Acids tyrosine 0.03%w/v; tryptophan 0.027%w/v; phenylalanine 0.057%w/v; threonine 0.064%w/v; L-serine 0.051%w/v; L-proline 0.058%w/v; glycine 0.051%w/v; L-alanine 0.095%w/v; valine 0.139%w/v; methionine 0.085%w/v; isoleucine 0.085%w/v; leucine 0.102%w/v; lysine 0.095%w/v; histidine 0/071%w/v; arginine 0.107%w/v; calcium chloride 0.018%w/v; magnesium chloride 0.005%w/v; sodium chloride 0.538%w/v; sodium s-lactate 0.448%w/v
Nutrineal PD4 with 1.1% Amino Acids türosiin 0.03%w/v; trüptofaan 0.027%w/v; fenüülalaniin 0.057%w/v; treoniin 0.064%w/v; Lseriin 0.051%w/v; L-proliin 0.058%w/v; glütsiin 0.051%w/v; Lalaniin 0.095%w/v; valiin 0.139%w/v; metioniin 0.085%w/v; isoleutsiin 0.085%w/v; leutsiin 0.102%w/v; lüsiin 0.095%w/v; histidiin 0/071%w/v; arginiin 0.107%w/v; kaltsiumkloriid 0.018%w/v; magnersiumkloriid 0.005%w/v; naatriumkloriid 0.538%w/v; naatrium-s-laktaat 0.448%w/v
Pouet de Camilo 2
Hispaania Baxter S.L Pouet de Camilo, 2
6.43, Calcium Chloride Dihydrate Ph. Eur.
6.43, Kaltsiumkloriiddihüdraat Ph. Eur.
Eur., 0.257, Magnesium Chloride Hexahydrate Ph. Eur.0.152, Sodium Lactate Ph. Eur.
Magneesiumkloriidheksahüdraat Ph. Eur.0.152, Naatriumlaktaat Ph. Eur.
BAXTER d.o.o.,Zelezna cesta 18, 1000 Ljubljana Slovenia
Bulgaaria BAXTER d.o.o.,Zelezna cesta 18, 1000 Ljubljana, Slovenia
Baxter Healthcare S.A. Moneen Road Castlebar, Co. Mayo Ireland
Baxter Healthcare S.A. Moneen Road Castlebar, CO. Mayo lreland
0.714 g L-Arginine Ph.Eur.
0.714 g L-Arginiin Ph.Eur.
Baxter Healthcare Ltd., Caxton Way, Thetford,
Baxter Healthcare Ltd Caxton Way,
Icodextrin (75 g/l), Sodium chloride (5.4 g/l), Calcium chloride (0.257 g/l), Magnesium chloride (0.051 g/l), Sodium lactate solution (4.5 g/l)
Ikodekstriin (75 g/l), Naatriumkloriid (5.4 g/l), Kaltsiumkloriid (0.257 g/l), Magneesiumkloriid (0.051 g/l), Naatriumlaktaadi lahus (4.5 g/l)
0.850 g, L-Isoleucine Ph.Eur.
0.850 g, L-Isoleutsetiin Ph.Eur.
1.393 g, LMethionine Ph.Eur.
1.393 g, L-Metioniin Ph.Eur.
1.020 g, LLysine hydrochloride Ph.Eur.
1.020 g, L-Lüsiinhüdrokloriid Ph.Eur.
3.86 % w/v or Glucose Monohydrate Ph.Eur.
3.86 % w/v or Glükoosmonohüdraat Ph.Eur.
0.850 g, L-Leucine Ph.Eur.
0.850 g, L-Leutsiin Ph.Eur.
solution for haemodialysis, haemodiafiltration and haemofiltration intraarterial use, intravenous use, hemodialysis
Hemodialüüsi,hemodiafiltratsioonija hemofiltratsioonilahus intraarteriaalne, intravenoosne,
1.36 % w/v or Glucose Monohydrate Ph.Eur.
1.36 % w/v or Glükoosmonohüdraat Ph.Eur.
0.57 % w/v Sodium Lactate Ph.Eur.
0.57 % w/v Naatriumlaktaat Ph.Eur.
2.27 % w/v or Glucose Monohydrate Ph.Eur.
2.27 % w/v or Glükoosmonohüdraat Ph.Eur.
Dianeal PD1 Glucose 2.27% w/v /22.7mg/ml sodium chloride 0.57%w/v; glucose 2.27%w/v; magnesium chloride 0.015%w/v; sodium lactate 0.39%w/v; calcium chloride 0.026%w/v
Dianeal PD1 Glucose 2.27% w/v /22.7mg/ml naatriumkloriid 0.57%w/v; glükoos 2.27%w/v; magneesiumkloriid 0.015%w/v; naatriumlaktaat 0.39%w/v; kaltsiumkloriid 0.026%w/v
0.595 g, Glycine Ph.Eur.
0.595 g, Glütsiin Ph.Eur.
Anhydrous Glucose Ph.Eur.
Veevaba glüskoos Ph.Eur.
75 mg/ml Icodextrin; 5,4 mg/ml Sodium Chloride; 4,5 mg/ml Sodium (S) - lactate solution; 0,051 mg/ml Magnesium Chloride; 0,257 mg/ml Calcium Chloride
75 mg/ml Ikodekstriin; 5,4 mg/ml Naatriumkloriid; 4,5 mg/ml naatrium (S) - laktaadilahus; 0,051 mg/ml Magneesiumkloriid; 0,257 mg/ml Kaltsiumkloriid
1,1% amino acid
1,1% Aminohapped
Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alanine 951 mg/L, arginine 1071 mg/L, glycine 510 mg/L, histidine 714 mg/L, isoleucine 850 mg/L, leucine 1020 mg/L, lysine hydrochloride 955 mg/L, methionine 850 mg/L, phenylalanine 570 mg/L, proline 595 mg/L, serine 510 mg/L, threonine 646 mg/L, tryptophan 270 mg/L, tyrosine 300 mg/L, valine 1393 mg/L, sodium chloride 5380 mg/L, calcium chloride dihydrate 184 mg/L, magnesium chloride hexahydrate 51 mg/L, sodium(s)-lactate 4480 mg/L
Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alaniini 951 mg/L, arginiini 1071 mg/L, glütsiin 510 mg/L, histidiin 714 mg/L, isoleutsiin 850 mg/L, leutsiin 1020 mg/L, lüsiin vesinikkloriidi 955 mg/L, metioniini 850 mg/L, fenüülalaniini 570 mg/L, proliini 595 mg/L, seriini 510 mg/L, treoniin 646 mg/L, trüptofaan 270 mg/L, türosiini 300 mg/L, valiin 1393 mg/L, Naatriumkloriid 5380 mg/L, Kaltsiumkloriid 184 mg/L, Magneesiumkloriid 51 mg/L, Naatrium(S)-laktaat 4480 mg/L
Glucose Monohydrate Ph. Eur.
Magneesiumkloriidheksahüdraat Ph. Eur.
0.955 g, LHistidine Ph.Eur.
0.955 g, L-Histidiin Ph.Eur.
Dianeal PD4 Glucose 2.27% w/v /22.7mg/ml magnseium chloride 0.005%w/v; glucose 2.27%w/v; sodium lactate 0.45%w/v; calcium chloride 0.018%w/v; sodium chloride 0.54%w/v
Dianeal PD4 Glucose 2.27% w/v /22.7mg/ml magneesiumkloriid 0.005%w/v; glükoos 2.27%w/v; naatriumlaktaat 0.45%w/v; kaltsiumkloriid 0.018%w/v; naatriumkloriid 0.54%w/v
1.36% W/V 2,27% W/V 3,86% W/V
2,27% w/v 3,86%w/v
L-Methionine 0.850 g/l L-Isoleucine 0.850 g/l L-Leucine 1.020 g/l L-Lysine (chlorhydrate) 0.955 g/l L-Histidine 0.714 g/l L-Arginine 1.071 g/l Calcium chloride dihydrate 0.184 g/l Magnesium chloride hexahydrate 0.051 g/l Sodium Lactate 4.48 g/l
L-Türosiin 0.300 g/l L-Trüptofaan 0.270 g/l L-Fenüülalaniin 0.570 g/l L-Treoniin 0.646 g/l L-Seriin 0.510 g/l L-Proliin 0.595 g/l Glütsiin 0.510 g/l L-Alaniin 0.951 g/l L-Valiin 1.393 g/l L-Metioniin 0.850 g/l L-Isoleutsiin 0.850 g/l L-Leutsiin 1.020 g/l L-Lüsiin (kloorhüdraat) 0.955 g/l L-Histidiin 0.714 g/l L-Arginiin 1.071 g/l Kaltsiumkloriiddihüdraat 0.184 g/l Magneesiumkloriidheksahüdraat 0.051 g/l
38.6 g/l glucose anhydrate
38.6 g/l Veevaba glükoos
0.270 g, L-Phenylalanine Ph.Eur.
0.270 g, LFenüülalaniin Ph.Eur.
Dianeal PD1 Glucose 1.36% w/v /13.6mg/ml magnesium chloride 0.015%w/v; calcium chloride 0.026%w/v; glucose 1.36%w/v; sodium lactate 0.39%w/v; sodium chloride 0.57%w/v
Dianeal PD1 Glucose 1.36% w/v /13.6mg/ml magneesiumkloriid 0.015%w/v; kaltsiumkloriid 0.026%w/v; glükoos 1.36%w/v; naatriumlaktaat 0.39%w/v; naatriumkloriid 0.57%w/v
Dianeal PD4 Glucose 1.36% w/v /13.6mg/ml magnseium chloride 0.005%w/v; glucose 1.36%w/v; sodium lactate 0.45%w/v; calcium chloride 0.018%w/v; sodium chloride 0.54%w/v
Dianeal PD4 Glucose 1.36% w/v /13.6mg/ml magneesiumkloriid 0.005%w/v; glükoos 1.36%w/v; naatriumlaktaat 0.45%w/v; kaltsiumkloriid 0.018%w/v; naatriumkloriid 0.54%w/v
Dianeal PD4 Glucose 3.86% w/v /38.6mg/ml magnseium chloride 0.005%w/v; glucose 3.86%w/v; sodium lactate 0.45%w/v; calcium chloride 0.018%w/v; sodium chloride 0.54%w/v
Dianeal PD4 Glucose 3.86% w/v /38.6mg/ml magneesiumkloriid 0.005%w/v; glükoos 3.86%w/v; naatriumlaktaat 0.45%w/v; kaltsiumkloriid 0.018%w/v; naatriumkloriid 0.54%w/v
Dianeal PD1 Glucose 3.86% w/v /38.6mg/ml magnesium chloride 0.015%w/v; calcium chloride 0.026%w/v; glucose 3.86%w/v; sodium lactate 0.39%w/v; sodium chloride 0.57%w/v
Dianeal PD1 Glucose 3.86% w/v /38.6mg/ml magneesiumkloriid 0.015%w/v; kaltsiumkloriid 0.026%w/v; glükoos 3.86%w/v; naatriumlaktaat 0.39%w/v; naatriumkloriid 0.57%w/v
1,071 mg/ml Arginine; 0,714 mg/ml Histine; 0,955 mg/ml Lysine hydrochloride; 1,02 mg/ml Leucine; 0,85 mg/ml Isoleucine; 0,85 mg/ml Methionine; 1,393 mg/ml Valine; 0,951 mg/ml Alanine; 0,51 mg/ml Glycine; 0,595 mg/ml Proline; 0,51 mg/ml Serine; 0,646 mg/ml Threonine; 0,57 mg/ml Phenylalanine; 0,27 mg/ml Tryptophan; 0,3 mg/ml Tyrosine; 0,184 mg/ml Calcium Chloride Dihydrate;
1,071 mg/ml Arginiin; 0,714 mg/ml Histiin; 0,955 mg/ml Lüsiinhüdrokloriid; 1,02 mg/ml Leutsiin; 0,85 mg/ml Isoleutsiin; 0,85 mg/ml Metioniin; 1,393 mg/ml Valiin; 0,951 mg/ml Alaniin; 0,51 mg/ml Glütsiin; 0,595 mg/ml Proliin; 0,51 mg/ml Seriin; 0,646 mg/ml Treoniin; 0,57 mg/ml Fenüülalaniin; 0,27 mg/ml Trüptofaan; 0,3 mg/ml Türosiin; 0,184 mg/ml
Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeistof
Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeis t of
13.6 g/l glucose anhydrate
13.6 g/l Veevaba glükoos
0.510 g, L-Proline Ph.Eur.
0.510 g, L-Proliin Ph.Eur.
Finland Baxter Healthcare S.A. Moneen Road, Castlebar County Mayo
Baxter Healthcare S.A. Moneen Road, Castlebar County Mayo Ireland
0.570 g, L-Threonine Ph.Eur.
0.570 g, LThreoniin Ph.Eur.
0.300 g, L-Tryptophan Ph.Eur.
0.300 g, LTrüptofaan Ph.Eur.
Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeistof
Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeis t of
22,7 g/l glucose anhydrate
22.7 g/l Veevaba glükoos
Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeistof
Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeis t of
22,7g+5,38g+4,48g+0,184g+0,051g/l
Dianeal PD4 Glucose 22,7g+5,38g+4,48g+0,184g+0,051 g/l
Dianeal PD4 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeistof
Dianeal PD4 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeis t of
Dianeal PD4 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeistof
Dianeal PD4 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeis t of
Dianeal PD4 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeistof
Dianeal PD4 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeis t of
3,86% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
3,86% w/v 0,538% w/v 0,448% w/v
0.510 g, L-Alanine Ph.Eur.
0.510 g, LAlaniin Ph.Eur.
1,36% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
1,36% w/v 0,538% w/v 0,448% w/v
Anhydrous glucose 22.7 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Veevaba glükoos 22.7 g/L, Naatriumkloriid 5.38 g/L, Naatrium(S)-laktaat 4.48 g/L, Kaltsiumkloriid 0,184 g/L, Magneesiumkloriid 0,051 g/L
solution for dialysis peritoneal
Solución para diálisis peritoneal
951 mg/l; 1071 mg/l; 510 mg/l; 714 mg/l; 850 mg/l; 1020 mg/l; 955 mg/l; 850 mg/l; 570 mg/l; 595 mg/l; 510 mg/l; 646 mg/l; 270 mg/l; 300 mg/l; 1393 mg/l; 5380 mg/l; 184 mg/l; 51 mg/l; 4480 mg/l
951 mg/l; 1071 mg/l; 510 mg/l; 714 mg/l; 850 mg/l; 1020 mg/l; 955 mg/l; 850 mg/l; 570 mg/l; 595 mg/l; 510 mg/l; 646 mg/l;
Glucose monohydrate 1.1 g/L, sodium chloride 6.43 g/L, sodium lactate 3.36 g/L, calcium chloride dihydrate 0.257 g/L, magnesium chloride hexahydrate 0.152 g/L, potassium chloride 0.298 g/L
Glükoosmonohüdraat 1.1 g/L, naatriumkloriid 6.43 g/L, naatriumlaktaat 3.36 g/L, kaltsiumkloriiddihüdraat 0.257 g/L, magneesiumkloriidheksahüdraat 0.152 g/L, kaaliumkloriid 0.298 g/L
Anhydrous glucose 38.6 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Veevaba glükoos 38.6 g/L, Naatriumkloriid 5.38 g/L, Naatrium(S)-laktaat 4.48 g/L, Kaltsiumkloriid 0,184 g/L, Magneesiumkloriid 0,051 g/L
Anhydrous glucose 13.6 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Veevaba glükoos 13.6 g/L, Naatriumkloriid 5.38 g/L, Naatrium(S)-laktaat 4.48 g/L, Kaltsiumkloriid 0,184 g/L, Magneesiumkloriid 0,051 g/L
Glucose monohydrate 1.1 g/L, sodium chloride 6.43 g/L, sodium lactate 3.36 g/L, calcium chloride dihydrate 0.257 g/L, magnesium chloride hexahydrate 0.152 g/L, potassium chloride 0.149 g/L
Glükoosmonohüdraat 1.1 g/L, naatriumkloriid 6.43 g/L, naatriumlaktaat 3.36 g/L, kaltsiumkloriiddihüdraat 0.257 g/L, magneesiumkloriidheksahüdraat 0.152 g/L, kaaliumkloriid 0.149 g/L
Calcium Chloride: 0.026% w/v. glucose 0.110%w/v; sodium lactate 0.336%w/v; sodium chloride 0.643%w/v; magnesium chloride 0.015%w/v solution for haemodialysis/hae mofiltration intraarterial use, intravenous use
0.110%w/v; naatriumlaktaat 0.336%w/v; naatriumkloriid 0.643%w/v; magneesiumkloriid 0.015%w/v
38,6g+5,38g+4,48g+0,184g+0,051g/l
Dianeal PD4 Glucose 38,6g+5,38g+4,48g+0,184g+0,051 g/l
42,5 mg/ml Glucose Monohydrate; 5,38 mg/ml Sodium Chloride; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 4,48 mg/ml Sodium Lactate
42,5 mg/ml Glükoosmonohüdraat; 5,38 mg/ml Naatriumkloriid; 0,184 mg/ml Kaltsiumkloriiddihüdraat; 0,051 mg/ml
42,5 mg/ml Glucose Monohydrate; 5,67 mg/ml Sodium Chloride; 0.257 mg/ml Calcium Chloride Dihydrate; 0,152 mg/ml Magnesium Chloride Hexahydrate; 3,92 mg/ml Sodium Lactate
42,5 mg/ml Glükoosmonohüdraat; 5,67 mg/ml Naatriumkloriid; 0,257 mg/ml Kaltsiumkloriiddihüdraat; 0,152 mg/ml
Dianeal PD4 med glucos 13,6 mg/ml
Dianeal PD4 Glucose 13,6 mg/ml
1.1 g / l 6.43 g / l 0.257 g / l 0.298 g / l 0.152 g / l 3.36 g / l solution for haemodialysis hemodialysis
1.1 g / l 6.43 g / l 0.257 g / l 0.298 g / l 0.152 g / l 3.36 g / l
13,6g+5,38g+4,48g+0,184g+0,051g/l
Dianeal PD4 Glucose 13,6g+5,38g+4,48g+0,184g+0,051 g/l
Ireland Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk, IP24 3SE, United Kingdom
Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk, IP24 3SE United Kingdom
1.1 g / l 6.43 g / l 0.257 g / l 0.149 g / l 0.152 g / l 3.36 g / l solution for haemodialysis hemodialysis
1.1 g / l 6.43 g / l 0.257 g / l 0.149 g / l 0.152 g / l 3.36 g / l
Sodium Chloride 5.38 g/l Quantitative Composition of Sodium Lactate Lactic Acid 139 g
Naatriumlaktaat 4.48 g/l Naatriumkloriid 5.38 g/l Naatriumlaktaadi kvantitatiivne koostis
15 mg/ml Glucose Monohydrate; 5,38 mg/ml Sodium Chloride; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 4,48 mg/ml Sodium Lactate
15 mg/ml Glükoosmonohüdraat; 5,38 mg/ml Naatriumkloriid; 0,184 mg/ml Kaltsiumkloriiddihüdraat; 0,051 mg/ml
15 mg/ml Glucose Monohydrate; 5,67 mg/ml Sodium Chloride; 0,257 mg/ml Calcium Chloride Dihydrate; 0,152 mg/ml Magnesium Chloride Hexahydrate; 3,92 mg/ml Sodium Lactate
15 mg/ml Glükoosmonohüdraat; 5,67 mg/ml Naatriumkloriid; 0,257 mg/ml Kaltsiumkloriiddihüdraat; 0,152 mg/ml
25 mg/ml Glucose Monohydrate; 5,67 mg/ml Sodium Chloride; 0,257 mg/ml Calcium Chloride Dihydrate; 0,152 mg/ml Magnesium Chloride Hexahydrate; 3,92 mg/ml Sodium Lactate
25 mg/ml Glükoosmonohüdraat; 5,67 mg/ml Naatriumkloriid; 0,257 mg/ml Kaltsiumkloriiddihüdraat; 0,152 mg/ml
Annex I
Ühendkuningri ik
25 mg/ml Glucose Monohydrate; 5,38 mg/ml Sodium Chloride; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 4,48 mg/ml Sodium Lactate
25 mg/ml Glükoosmonohüdraat; 5,38 mg/ml Naatriumkloriid; 0,184 mg/ml Kaltsiumkloriiddihüdraat; 0,051 mg/ml
Dianeal PD4 med glucos 38,6 mg/ml
Dianeal PD4 Glucose 38,6 mg/ml
0.051 g, Sodium-lactate Ph.Eur.
0.051 g, Naatrium(S)laktaat Ph.Eur.